- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/08 - 1,2,5-OxadiazolesHydrogenated 1,2,5-oxadiazoles
Patent holdings for IPC class C07D 271/08
Total number of patents in this class: 190
10-year publication summary
|
19
|
37
|
23
|
6
|
14
|
2
|
7
|
5
|
4
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Holdings Corporation | 625 |
18 |
| Bayer Cropscience AG | 1846 |
17 |
| BASF SE | 21303 |
10 |
| Incyte Corporation | 1072 |
8 |
| Bayer Intellectual Property GmbH | 2379 |
6 |
| Incyte Holdings Corporation and Incyte Corporation | 70 |
6 |
| Bayer AG | 3495 |
5 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 193 |
5 |
| Dice Alpha, Inc. | 27 |
5 |
| Nanjing Huawe Medicine Technology Group Co., Ltd. | 10 |
4 |
| Merck Sharp & Dohme LLC | 3735 |
4 |
| Hinova Pharmaceuticals Inc. | 102 |
3 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 376 |
3 |
| Nicox S.A. | 144 |
3 |
| Shandong Luye Pharmaceutical Co., Ltd. | 66 |
3 |
| Shanghai Hansoh Biomedical Co., Ltd. | 355 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Galderma Research & Development | 351 |
2 |
| Hangzhou Normal University | 70 |
2 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
2 |
| Other owners | 79 |